-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Gettex System der Börse MünchenEURSymbol PX91-
CASSAVA SCIENCES INCBörse Gettex System der Börse MünchenEURSymbol PX91
-
CASSAVA SCIENCES INCBörse Börse DüsseldorfEURSymbol PX91
-
CASSAVA SCIENCES INCBörse Börse StuttgartEURSymbol PX91
-
CASSAVA SCIENCES INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol PX91
-
CASSAVA SCIENCES INCBörse Quotrix System der Börse DüsseldorfEURSymbol PX91
-
Cassava SciencesBörse NasdaqISIN US14817C1071 WKN: A2PGL8USDSymbol SAVA
-
ISIN US14817C1071 WKN: A2PGL8USDSymbol SAVA
-
EURSymbol PX91
-
EURSymbol PX91
-
EURSymbol PX91
-
MXN
-
Symbol PX91
Währung
EUR
Börse
Gettex System der Börse München Zeitzone: Europe/Berlin
Firmenname
Cassava Sciences, Inc
Marktkapitalisierung
2.615.467.488 (+- 23%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
2.011.934.976 oder 3.219.000.000
Mitarbeiter
18 (+- 49%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
9 oder 26 Mitarbeiter
EBITDA -4.572.000
PEGRatio None
Buchwert 0.937
Dir gefallen die Informationen zu Cassava Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Cassava Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Cassava Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Cassava Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
60 News & Informationen zur Cassava Sciences Aktie
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 103 companies hit new 52-week highs.
Things to Consider: Microsoft (NASDAQ:MSFT) was the largest company by market cap to …
2 High-Risk, High-Reward Stocks That Could Go to the Moon
Risk-averse investors may want to look elsewhere.
Here's Why Cassava Sciences Is Surging Today
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.
3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021
Cassava Sciences To Present New Clinical Dataset At 2021 Alzheimer's Association International Conference
– On Monday, July 26 th , New Clinical Data for SavaDx to be Shared in a Poster Presentation –
– On Thursday, July 29 th , New Clinical Data for
Big Rebound as Fear Subsides and Netflix Reports
Stocks Analysis by Zacks Investment Research covering: Alcoa Corp, Marvell Technology Group Ltd, CSX Corporation, Texas Instruments Incorporated. Read Zacks Investment Research's latest article on Investing.com
Building A Bear-Proof Portfolio: Investing Safely Up As The Fear & Greed Index Approaches Early 2020 Levels.
Market Fear Gauge Approaches 2020 Levels As ZeroHedge reported on Monday, the Fear & Greed gauge has approached early 2020 lev…
Here's Why Cassava Sciences Is Up 1,152% in the First Half of 2021
This small-cap biotech has shot up in value as the company's Alzheimer's drug makes it way through clinical trials.
Why Is Cassava Sciences Stock Soaring in 2021?
The stock market is excited by the clinical trial results for its Alzheimer's drug.
Cassava Sciences Is On The Brink Of Making Medical History (NASDAQ:SAVA)
Cassava Sciences has the proper science to take on a $100 billion industry desperately in need of new approaches.
Is BioCryst Pharmaceuticals, Inc. (BCRX) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
Cassava Sciences (SAVA) to Post Q2 Earnings: What's in Store?
Investors will be keen on updates from on its lead candidate, sumifilam, for Alzheimer's disease when Cassava (SAVA) reports Q2 results.
Golden Green, Inc. Buys Alerian MLP ETF, InfraCap MLP ETF, Oil States International Inc, Sells iShares U.S. Preferred Stock, Invesco Preferred ETF, PIMCO Dynamic Income Fund
GuruFocus Article or News written by insider and the topic is about:
Why Cassava Sciences Stock Moved Higher Monday
The biotech stock bounced back big Monday after tumbling on Friday.
Is Ironwood Pharmaceuticals, Inc. (IRWD) A Good Stock To Buy?
Is Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) a good place to invest some of your money right now? We can gain invaluable insight to help us answer…
Stocks Take a Breather and Pull Back from New Highs
Stocks Analysis by Zacks Investment Research covering: Alcoa Corp, Micron Technology Inc, CF Industries Holdings Inc, Cassava Sciences Inc. Read Zacks Investment Research's latest article on Investing.com
Why Biotech & Penny Stocks Have The Attention Of Retail Traders In 2021
Penny Stocks & 5 Stats To Know If You’re Trading Or Investing In 2021
5 Ultra-Popular Stocks to Avoid Like the Plague in July
Investors should think twice before putting their money to work in these businesses.
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) advancing …
This Biotech Stock Is Beating GameStop
Now the question is whether the gains are here to stay.
Reopening Stocks Fuel $6 Trillion Boom in a Post-Pandemic Market
(Bloomberg) — A $6 trillion boom in U.S. equities to open 2021 is leaving the pandemic’s winners in the dust as investors shift their focus to companies taking…
Is It Too Late to Buy Cassava Sciences Stock?
Just because the stock has had a massive run doesn't mean its biggest gains are behind it.
Could Cassava Sciences Be a Millionaire-Maker Stock?
Can this biotech underdog develop an Alzheimer's drug investors can count on?
4 Trending Health Care Stocks To Watch Right Now
Could these health care stocks maintain their growth momentum?
Cassava Sciences (SAVA) is Overbought: Is A Drop Coming?
Cassava Sciences (SAVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Dow Soars Nearly 600 Points as Stocks Stage Big Comeback
Stocks Analysis by Zacks Investment Research covering: Alcoa Corp, Cassava Sciences Inc, American Axle & Manufacturing, Cornerstone Building Brands Inc. Read Zacks Investment Research's latest article on Investing.com
Should I Avoid Black Stone Minerals LP (BSM)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…
Why Cassava Sciences Stock Soared Today
Investors applauded the company's update on its clinical programs.
Cassava Sciences chooses CRO for phase 3 Alzheimer's trial (NASDAQ:SAVA)
Cassava Sciences has selected Premier Research International as the contract research organization to help conduct the phase 3 trial of its Alzheimer's candidate simufilam.
Cassava Sciences Selects Clinical Research Organization For Phase 3 Clinical Program In Alzheimer's Disease
AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced
Cassava Sciences Provides Mid-Year Corporate Update, Clinical Development Progress And Announces Guidance On Clinical Data Release
Open-label Study Completes Patient Enrollment
Cognition Maintenance Study Initiated May 2020, now 30% Enrolled
6-month Biomarker Data to be
Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Cassava Sciences, Inc. (SAVA) closed at $34.85, marking a -0.68% move from the previous day.
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ:LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the …
ACOR Rises On Restructuring, ALXN Pauses COVID-19 Trial, SYBX On Watch
Today's Daily Dose brings you news about Acorda's restructuring; Alexion's decision to pause its COVID-19 trial; and analyst's rating on Synlogic..
S&P, NASDAQ Move Higher for Second Straight Session
Stocks Analysis by Zacks Investment Research covering: Apple Inc, Amazon.com Inc, Marriott International Inc, Netflix Inc. Read Zacks Investment Research's latest article on Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02% By Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02%
4 Reasons Cassava Sciences Could Be The Best-Performing Stock Of 2021 (NASDAQ:SAVA)
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (NASDAQ:SAVA) a clinical-stage biotechnology company focused on Alzheimer’s disease, …